The Neutrophil-to-Lymphocyte Ratio as a Biomarker in Metastatic Castrate-Sensitive Prostate Cancer Patients Treated with Abiraterone Acetate

The Neutrophil-to-Lymphocyte Ratio as a Biomarker in Metastatic Castrate-Sensitive Prostate Cancer Patients Treated with Abiraterone Acetate

Given its known prognostic role, we aimed to investigate the role of neutrophil–lymphocyte ratio (NLR) as a biomarker in metastatic castration-resistant prostate cancer (mCRPC) patients receiving ADT, either as monotherapy or in conjunction with abiraterone acetate (AA) and prednisone. This retrospe...

Full description

Saved in:
Bibliographic Details
Main Authors: Caio Vinícius Suartz, Marie-Laurence Roy, Paul Toren
Format: Article
Language:English
Published: MDPI AG 2024-08-01
Series:Société Internationale d’Urologie Journal
Subjects:
prostate cancer
abiraterone acetate
metastatic castrate sensitive prostate cancer
neutrophil-to-lymhocyte ratio
biomarker
Online Access:https://www.mdpi.com/2563-6499/5/4/44
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items